Publications by authors named "Kudsi S"

Orofacial pain is one of the most common causes of chronic pain leading to physical and cognitive disability. Several clinical and pre-clinical studies suggest that chronic pain results in cognitive impairment. However, there is a lack of meta-analyses examining the effects of orofacial pain models on behavioral learning and memory in rodents.

View Article and Find Full Text PDF
Article Synopsis
  • Parkinson's disease (PD) affects about 1% of people over 60 and can lead to significant non-motor issues, including radicular neuropathic pain, which can severely impact patients' lives.
  • A systematic review involving 36 low-bias studies found that the prevalence of radicular neuropathic pain in PD patients is 12.7%, with no significant differences based on diagnosis duration, medication dosage, or disease severity.
  • The study highlights a concerning underdiagnosis of this pain type in PD patients, indicating an urgent need for improved diagnostic methods and treatment strategies.
View Article and Find Full Text PDF

Complex regional pain syndrome type I (CRPS-I) is a disabling pain condition without adequate treatment. Chronic post-ischemia pain injury (CPIP) is a model of CRPS-I that causes allodynia, spontaneous pain, inflammation, vascular injury, and oxidative stress formation. Antioxidants, such as alpha lipoic acid (ALA), have shown a therapeutic potential for CRPS-I pain control.

View Article and Find Full Text PDF

Musculoskeletal pain is a widely experienced public healthcare issue, especially after traumatic muscle injury. Besides, it is a common cause of disability, but this pain remains poorly managed. However, the pathophysiology of traumatic muscle injury-associated pain and inflammation has not been fully elucidated.

View Article and Find Full Text PDF

Background: Musculoskeletal pain is a condition that affects bones, muscles, and tendons and is present in various diseases and/or clinical conditions. This type of pain represents a growing problem with enormous socioeconomic impacts, highlighting the importance of developing treatments tailored to the patient's needs. TRP is a large family of non-selective cation channels involved in pain perception.

View Article and Find Full Text PDF

Aims: This article aims to analyze the baseline distribution of TRPA1, TRPV1, TRPV4, and TRPM8 channels in human systems at the transcriptional level.

Main Methods: Using the RNA-seq dataset from the National Center for Biotechnology Information (NCBI) gene database, we investigated and compared the transcriptional levels of TRPV1, TRPA1, TRPV4 and TRPM8 found in 95 human subjects representing 33 different tissues to determine the tissue specificity of all protein-coding genes.

Key Finding: In this study, we observed higher transcriptional levels for TRPV1 (duodenum), TRPA1 (Urinary bladder), TRPV4 (Kidney) and TRPM8 (Prostate) compared to the other TRPs.

View Article and Find Full Text PDF
Article Synopsis
  • * This systematic review and meta-analysis aimed to estimate the prevalence of these psychiatric disorders in MS patients, analyzing different subgroups based on factors like type of MS and disability status.
  • * The findings indicated a prevalence of 27.01% for depression and 35.19% for anxiety across all MS patients, revealing variations based on MS subtype and disability levels, thereby highlighting the need for better-targeted treatments.
View Article and Find Full Text PDF

Headaches are frequently described in progressive multiple sclerosis (PMS) patients, but their mechanism remains unknown. Transient receptor potential ankyrin 1 (TRPA1) was involved in neuropathic nociception in a model of PMS induced by experimental autoimmune encephalomyelitis (PMS-EAE), and TRPA1 activation causes periorbital and facial nociception. Thus, our purpose was to observe the development of periorbital mechanical allodynia (PMA) in a PMS-EAE model and evaluate the role of TRPA1 in periorbital nociception.

View Article and Find Full Text PDF

Progressive multiple sclerosis (PMS) is a neurological disease associated with the development of depression and anxiety, but treatments available are unsatisfactory. The transient receptor potential ankyrin 1 (TRPA1) is a cationic channel activated by reactive compounds, and the blockage of this receptor can reduce depression- and anxiety-like behaviors in naive mice. Thus, we investigated the role of TRPA1 in depression- and anxiety-like behaviors in a PMS model in mice.

View Article and Find Full Text PDF

Muscle pain is the most prevalent type of pain in the world, but treatment remains ineffective. Thus, it is relevant to develop trustable animal models to understand the involved pain mechanisms. Therefore, this study characterised the nociception and inflammation in a traumatic muscle injury model in rats.

View Article and Find Full Text PDF
Article Synopsis
  • Arachis hypogaea L. (peanut) leaves, used for treating insomnia in Asia, were tested for safety and toxicity in a study involving repeated treatment with a hydroalcoholic extract in rats.
  • The study found no significant adverse effects on mortality, weight, locomotor activity, or anxiety behavior after administering doses of 100, 300, or 1000 mg/kg over 28 days.
  • While some changes were noted in liver and kidney weights and increased total thiols in female rats, overall, the extract did not show toxicity or harmful effects in the test subjects.
View Article and Find Full Text PDF

Complex regional pain syndrome type I (CRPS-I) is characterized by intractable chronic pain. Poor understanding of the underlying mechanisms of CRPS-I accounts for the current unsatisfactory treatment. Antioxidants and antagonists of the oxidative stress-sensitive channel, the transient receptor potential ankyrin 1 (TRPA1), have been found to attenuate acute nociception and delayed allodynia in models of CRPS-I, evoked by ischemia and reperfusion (I/R) of rodent hind limb (chronic post ischemia pain, CPIP).

View Article and Find Full Text PDF

Central neuropathic pain is a common untreated symptom in progressive multiple sclerosis (PMS) and is associated with poor quality of life and interference with patients' daily activities. The neuroinflammation process and mitochondrial dysfunction in the PMS lesions generate reactive species. The transient potential receptor ankyrin 1 (TRPA1) has been identified as one of the major mechanisms that contribute to neuropathic pain signaling and can be activated by reactive compounds.

View Article and Find Full Text PDF

Central neuropathic pain is the main symptom caused by spinal cord lesion in relapsing-remitting multiple sclerosis (RRMS), but its management is still not effective. The transient receptor potential ankyrin 1 (TRPA1) is a pain detecting ion channel involved in neuropathic pain development. Thus, the aim of our study was to evaluate the role of TRPA1 in central neuropathic nociception induced by relapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE) mouse model.

View Article and Find Full Text PDF

Breast carcinoma causes severe pain, which decreases the quality of life of patients. Current treatments produce adverse effects and have limited efficacy. Transient potential receptor ankyrin 1 (TRPA1) is related to the onset of cancer and neuropathic pain.

View Article and Find Full Text PDF
Article Synopsis
  • Complex regional pain syndrome I (CRPS-I) remains an inadequately treated chronic pain condition, and the study explores the potential of CTK 01512-2, a spider peptide with pain-blocking properties.
  • Using a CPRS-I mouse model, researchers investigated pain response through mechanical and cold sensitivity tests, revealing significant inflammatory changes during the acute phase but not in chronic pain.
  • CTK 01512-2 demonstrated effective pain relief in both acute and chronic phases, highlighting its potential as a therapeutic option for managing CRPS-I pain and inflammation.
View Article and Find Full Text PDF